The device, which is in the early stages of development, would function much like a pregnancy test, said Cathy Tarnowski, senior technical manager at 3M.
Florida has set a record for new coronavirus cases confirmed in a single day. The state's total is now higher than the total number of cases in countries like Spain, Italy or France.
Eager to streamline the process of drug development during the pandemic, researchers, pharmaceutical companies and a handful of tech start-ups have started virtual clinical trials, also known as remote or decentralized trials.
The U.S reported more than 30,000 new coronavirus cases on Friday and Saturday, the highest daily totals since May 1, according to data compiled by Johns Hopkins University. New cases across the country are surging faster than ever, especially in states in the South, West and Midwest. The largest single-day increase in global coronavirus cases was recorded on Sunday, according to the World Health Organization, after more than 183,000 new cases were reported worldwide.
Some kids could soon have a doctor's note prescribing video game play to treat ADHD.
Moderna is the front-runner in the race for a Covid-19 vaccine. Its CEO sees an 80% to 90% chance of success.
Groupon co-founder Eric Lefkofsky discovered the health-care system's flawed approach to data when his wife got cancer. Tempus is now on the front lines of the coronavirus fight. It made the CNBC 2020 Disruptor 50 list.
The Food and Drug Administration said it is ending its emergency use authorization for chloroquine and hydroxychloroquine, the anti-malaria drugs backed by President Donald Trump to combat Covid-19. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins "Squawk Box" to discuss.
Texas has reported two consecutive days of record-breaking Covid-19 hospitalizations as the state continues to open businesses and resume activities that were temporarily shuttered due to the coronavirus. There are currently 2,056 patients sickened with Covid-19 in hospitals across the state as of early Tuesday afternoon, up from a record 1,935 patients Monday, according to updated data from the Texas Department of State Health Services.
It was once thought "immunity passports" would be the golden ticket to travel the world. But experts are now sounding the alarm against them.
With much of the focus on Covid-19 vaccines and treatments, there's growing concern of a possible slowdown in the FDA's drug review process for treatment of other illnesses. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins "Squawk Box" to discuss.
As the race to develop a Covid-19 vaccine heats up, a debate is arising over how to balance expediency with safety measures. Watch five experts weigh in on how companies developing a vaccine can handle the issue.
Scientists in Singapore are developing a vaccine for the coronavirus, with hopes that early-stage clinical trials could come as soon as next month, according to a professor at Duke-NUS Medical School.
Dr. Anthony Fauci warned Congress that some states are prematurely reopening businesses, risking additional outbreaks and deaths, particularly among the most vulnerable populations.
BioAegis is awaiting FDA approval to test its plasma gelsolin therapy on Covid-19 patients. The company says its treatment prevents damage from excess inflammation without suppressing the immune system and is the best defense against the virus.
Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins "Squawk Box" to discuss what the latest medical research says about Covid-19's effect on children.
Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins "Squawk Box" to discuss why he says antibody testing could be the key to stopping the spread of coronavirus if we make sure the tests are reliable.
Most experts agree that Covid-19 testing is vital to safely reopen the economy. But getting to scale presents challenges, they say.
Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, tells "Squawk Box" that a Covid-19 vaccine could be made available for use in "selected circumstances" before it receives official approval for wider distribution.
Moderna CEO Stephan Bancel tells "Squawk Box" that he anticipates the supply of Covid-19 vaccines will be 'constrained' at first and that the company will work closely with the U.S. government to distribute the first batches of the vaccine to areas that have the most need.
Data also provided by 
